Today, an analyst has provided a rating update for the Healthcare company, CannTrust Holdings Inc (TRST). Analyst Owen Bennett from Jefferies remains bullish on the stock and has a C$13 price target.
According to TipRanks.com, Bennett is a 1-star analyst with an average return of -1.7% and a 47.1% success rate. Bennett covers the Healthcare sector, focusing on stocks such as The Green Organic Dutchman Holdings Ltd, CannTrust Holdings Inc, and Aurora Cannabis Inc.
CannTrust Holdings Inc has an analyst consensus of Moderate Buy, with a price target consensus of C$14, a 72.8% upside from current levels. In a report issued on April 22, Paradigm also reiterated a Buy rating on the stock with a C$17 price target.
.
The company has a one-year high of C$15.50 and a one-year low of C$5.94. Currently, CannTrust Holdings Inc has an average volume of 2.23M.
CannTrust Holdings, Inc. engages in the production and distribution of medical cannabis. It focuses on developing nanotechnology to create new products in the medical, recreational, beauty, wellness, and pet markets. The company was founded by Norman Paul and Eric Paul on March 16, 2015 and is headquartered in Vaughan, Canada.
The company’s shares closed on Friday at C$8.10.
